FDA

News and Updates by the Food and Drugs Administration (FDA)

Lupin Digital Health Joins Forces with Medicover Hospitals for Enhanced Cardiac Care After Discharge

Lupin Digital Health, a fully-owned unit of the global pharmaceutical powerhouse Lupin Limited, has unveiled a pioneering alliance with Medicover Hospitals. This transformative collaboration aims to deliver top-tier post-surgical rehabilitation and care for Medicover’s cardiac patients, ushering in a new […]

Lupin Digital Health Joins Forces with Medicover Hospitals for Enhanced Cardiac Care After Discharge Read More »

2024 FPME Annual Conference Celebrates Global Supply Chain Strength and Quality Mastery Through Partnerships

The pharmaceutical export sector assembled in Mumbai for the eagerly awaited “Know Your Value” event, spotlighting the vital roles of the Government, Directorate General of Foreign Trade (DGFT), Central Drugs Standard Control Organization (CDSCO), and Customs in supporting pharmaceutical exports

2024 FPME Annual Conference Celebrates Global Supply Chain Strength and Quality Mastery Through Partnerships Read More »

Kiran Mazumdar-Shaw Receives ISQ’s Esteemed ‘Jamsetji Tata Award’ for Advancing Biosciences in India

The chairperson of Biocon Group, Kiran Mazumdar-Shaw, has been awarded the renowned Jamsetji Tata Award by the Indian Society for Quality (ISQ). This accolade recognizes her groundbreaking role in advancing the biosciences movement within India and her dedication to serving

Kiran Mazumdar-Shaw Receives ISQ’s Esteemed ‘Jamsetji Tata Award’ for Advancing Biosciences in India Read More »

Anesthetic Pharmaceuticals: Ketamine, Propofol, and Bupivacaine Specifications in Current Tender

Indian Military Procurement Notice Goods Healthcare and Medicine GEM Jammu, Jammu & Kashmir Opening Date 11 Dec 2024 Closing Date 1 Jan 2025 Tender Amount ? 9,49,868  Costs EMD Refer to Documents Document Fee Consult Documents Application Fee Check Documentation Details

Anesthetic Pharmaceuticals: Ketamine, Propofol, and Bupivacaine Specifications in Current Tender Read More »

Nyxoah Brings Genio Neurostimulation System to England for Obstructive Sleep Apnoea Treatment

Nyxoah SA (Nyxoah), a pioneering medical technology firm, recently launched its innovative Genio system in England to address obstructive sleep apnoea (OSA) with neuromodulation techniques. This commercial introduction was celebrated with the initial successful procedures at University College London Hospitals

Nyxoah Brings Genio Neurostimulation System to England for Obstructive Sleep Apnoea Treatment Read More »

Scientists Discover Crucial Regulator Enhancing Tumor-Destroying T Cells in Low-Oxygen Conditions

The advent of immune checkpoint inhibitors has transformed the treatment landscape for several advanced cancers, yet a plateau in therapeutic response has emerged due to resistance, impairing tumor-infiltrating lymphocytes (TILs). To counteract this resistance and revitalize anti-cancer TILs, which are

Scientists Discover Crucial Regulator Enhancing Tumor-Destroying T Cells in Low-Oxygen Conditions Read More »